These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 35346798)

  • 1. Hemodynamically Tolerated Ventricular Tachycardia With Mildly Impaired Ejection Fraction: Do These Patients Have VT/VF Recurrence and ICD Therapies?
    Gula LJ; Frydman A; Khan HR; Klein GJ; Leong-Sit P; Manlucu J; Roberts JD; Tang ASL; Yee R; Skanes AC
    Can J Cardiol; 2022 Aug; 38(8):1271-1276. PubMed ID: 35346798
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dofetilide reduces the frequency of ventricular arrhythmias and implantable cardioverter defibrillator therapies.
    Baquero GA; Banchs JE; Depalma S; Young SK; Penny-Peterson ED; Samii SM; Wolbrette DL; Naccarelli GV; Gonzalez MD
    J Cardiovasc Electrophysiol; 2012 Mar; 23(3):296-301. PubMed ID: 21955243
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Implantable defibrillator event rates in patients with idiopathic dilated cardiomyopathy, nonsustained ventricular tachycardia on Holter and a left ventricular ejection fraction below 30%.
    Grimm W; Hoffmann J Jü; Müller HH; Maisch B
    J Am Coll Cardiol; 2002 Mar; 39(5):780-7. PubMed ID: 11869841
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk of malignant ventricular arrhythmias in patients with mildly to moderately reduced ejection fraction after permanent pacemaker implantation.
    Dai M; Peterson C; Chorin U; Leiva O; Katz M; Sliman H; Aizer A; Barbhaiya C; Bernstein S; Holmes D; Knotts R; Park D; Spinelli M; Chinitz L; Jankelson L
    Heart Rhythm; 2024 Aug; 21(8):1308-1316. PubMed ID: 38490597
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk of ventricular arrhythmias following implantable cardioverter-defibrillator generator change in patients with recovered ejection fraction: Implications for shared decision-making.
    Chang DD; Pantlin PG; Benn FA; Ryan Gullatt T; Bernard ML; Elise Hiltbold A; Khatib S; Polin GM; Rogers PA; Velasco-Gonzalez C; Morin DP
    J Cardiovasc Electrophysiol; 2023 Jun; 34(6):1405-1414. PubMed ID: 37146210
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ventricular tachycardia/fibrillation early after defibrillator implantation in patients with hypertrophic cardiomyopathy is explained by a high-risk subgroup of patients.
    Alsheikh-Ali AA; Link MS; Semsarian C; Shen WK; Estes NA; Maron MS; Haas TS; Formisano F; Boriani G; Spirito P; Maron BJ
    Heart Rhythm; 2013 Feb; 10(2):214-8. PubMed ID: 23041573
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ventricular arrhythmia detection for contemporary Biotronik and Abbott implantable cardioverter defibrillators with markedly prolonged detection in Biotronik devices.
    Oesterle A; Dhruva SS; Pellegrini CN; Liem B; Raitt MH
    J Interv Card Electrophysiol; 2023 Oct; 66(7):1679-1691. PubMed ID: 36737506
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term follow-up in patients with arrhythmogenic right ventricular cardiomyopathy.
    Li CH; Lin YJ; Huang JL; Wu TJ; Cheng CC; Lin WS; Tuan TC; Chang SL; Lo LW; Hu YF; Chao TF; Chung FP; Tsai CF; Tsao HM; Chen SA
    J Cardiovasc Electrophysiol; 2012 Jul; 23(7):750-6. PubMed ID: 22353378
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Strategic programming of detection and therapy parameters in implantable cardioverter-defibrillators reduces shocks in primary prevention patients: results from the PREPARE (Primary Prevention Parameters Evaluation) study.
    Wilkoff BL; Williamson BD; Stern RS; Moore SL; Lu F; Lee SW; Birgersdotter-Green UM; Wathen MS; Van Gelder IC; Heubner BM; Brown ML; Holloman KK;
    J Am Coll Cardiol; 2008 Aug; 52(7):541-50. PubMed ID: 18687248
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Left ventricle remodeling predicts the recurrence of ventricular tachyarrhythmias in implantable cardioverter defibrillator recipients for secondary prevention.
    Lee WC; Chen HC; Chen YL; Tsai TH; Pan KL; Lin YS; Chen MC
    BMC Cardiovasc Disord; 2016 Nov; 16(1):231. PubMed ID: 27871248
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of ventricular tachyarrhythmia characteristics in patients with idiopathic dilated or ischemic cardiomyopathy and defibrillators implanted for primary prevention.
    Streitner F; Kuschyk J; Dietrich C; Mahl E; Streitner I; Doesch C; Veltmann C; Schimpf R; Wolpert C; Borggrefe M
    Clin Cardiol; 2011 Oct; 34(10):604-9. PubMed ID: 21887690
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ventricular Tachyarrhythmias in Patients With Hypertrophic Cardiomyopathy and Defibrillators: Triggers, Treatment, and Implications.
    Link MS; Bockstall K; Weinstock J; Alsheikh-Ali AA; Semsarian C; Estes NAM; Spirito P; Haas TS; Rowin EJ; Maron MS; Maron BJ
    J Cardiovasc Electrophysiol; 2017 May; 28(5):531-537. PubMed ID: 28240435
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Heart failure and the risk of shocks in patients with implantable cardioverter defibrillators: results from the Triggers Of Ventricular Arrhythmias (TOVA) study.
    Whang W; Mittleman MA; Rich DQ; Wang PJ; Ruskin JN; Tofler GH; Muller JE; Albert CM;
    Circulation; 2004 Mar; 109(11):1386-91. PubMed ID: 14993132
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Follow-up after hemodynamically not tolerated ventricular tachycardia in patients with midrange reduced to normal ejection fraction: A retrospective single-centre case series.
    Groeneveld SA; Blom LJ; van der Heijden JF; Loh P; Hassink RJ
    Eur J Clin Invest; 2021 Jan; 51(1):e13359. PubMed ID: 32705678
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term benefit of first-line peri-implantable cardioverter-defibrillator implant ventricular tachycardia-substrate ablation in secondary prevention patients.
    Acosta J; Cabanelas N; Penela D; Fernández-Armenta J; Andreu D; Borràs R; Korshunov V; Cabrera M; Vasanelli F; Arbelo E; Guasch E; Martínez M; Tolosana JM; Mont L; Berruezo A
    Europace; 2017 Jun; 19(6):976-982. PubMed ID: 27353322
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical and electrophysiologic predictors of ventricular tachyarrhythmia recurrence in patients with implantable cardioverter defibrillators.
    Gillis AM; Sheldon RS; Wyse DG; Duff HJ; Cassidy MR; Mitchell LB
    J Cardiovasc Electrophysiol; 2003 May; 14(5):492-8. PubMed ID: 12776866
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of spironolactone on ventricular tachyarrhythmias in patients with implantable cardioverter-defibrillators.
    Zarraga IG; Dougherty CM; MacMurdy KS; Raitt MH
    Circ Arrhythm Electrophysiol; 2012 Aug; 5(4):739-47. PubMed ID: 22773022
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ventricular tachyarrhythmia recurrence in primary versus secondary implantable cardioverter-defibrillator patients and role of electrophysiology study.
    Zaman S; Sivagangabalan G; Chik W; Stafford W; Hayes J; Denman R; Young G; Sanders P; Kovoor P
    J Interv Card Electrophysiol; 2014 Dec; 41(3):195-202. PubMed ID: 25267274
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Antitachycardia pacing in patients with left ventricular dysfunction and hemodynamically unstable arrhythmias].
    Oliveira M; Antunes E; da Silva N; Martins S; Conceição JM; Roquette J; Antunes AM
    Rev Port Cardiol; 1999 Feb; 18(2):161-6. PubMed ID: 10221046
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rapid ventricular tachycardia in patients with tetralogy of Fallot and implantable cardioverter-defibrillator: Insights from the DAI-T4F nationwide registry.
    Laredo M; Duthoit G; Sacher F; Anselme F; Audinet C; Bessière F; Bordachar P; Bouzeman A; Boveda S; Bun SS; Chassignolle M; Clerici G; Da Costa A; de Guillebon M; Defaye P; Elbaz N; Eschalier R; Extramiana F; Fauchier L; Hermida A; Gandjbakhch E; Garcia R; Gourraud JB; Guenancia C; Guy-Moyat B; Irles D; Iserin L; Jourda F; Koutbi L; Labombarda F; Ladouceur M; Lagrange P; Lellouche N; Mansourati J; Marquié C; Martins R; Massoulié G; Mathiron A; Maury P; Messali A; Milhem A; Mondoly P; Nguyen C; Ninni S; Pasquié JL; Pierre B; Pujadas P; Sellal JM; Thambo JB; Walton C; Winum P; Zakine C; Zhao A; Jouven X; Combes N; Marijon E; Waldmann V;
    Heart Rhythm; 2023 Feb; 20(2):252-260. PubMed ID: 36309156
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.